nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—CYP1A2—Betaxolol—glaucoma	0.104	0.151	CbGbCtD
Rilpivirine—CYP2C19—Methazolamide—glaucoma	0.0858	0.124	CbGbCtD
Rilpivirine—CYP2C19—Timolol—glaucoma	0.0729	0.106	CbGbCtD
Rilpivirine—CYP3A4—Pilocarpine—glaucoma	0.0614	0.089	CbGbCtD
Rilpivirine—ABCB1—Timolol—glaucoma	0.0588	0.0853	CbGbCtD
Rilpivirine—CYP1A2—Clonidine—glaucoma	0.0572	0.0829	CbGbCtD
Rilpivirine—ABCB1—Clonidine—glaucoma	0.05	0.0725	CbGbCtD
Rilpivirine—CYP3A4—Brinzolamide—glaucoma	0.0482	0.0698	CbGbCtD
Rilpivirine—CYP3A4—Dorzolamide—glaucoma	0.0465	0.0674	CbGbCtD
Rilpivirine—CYP3A4—Methazolamide—glaucoma	0.0415	0.0601	CbGbCtD
Rilpivirine—CYP3A4—Acetazolamide—glaucoma	0.0331	0.048	CbGbCtD
Rilpivirine—CYP3A4—Clonidine—glaucoma	0.03	0.0435	CbGbCtD
Rilpivirine—Decreased appetite—Methazolamide—glaucoma	0.0013	0.00433	CcSEcCtD
Rilpivirine—Urinary tract disorder—Brinzolamide—glaucoma	0.00129	0.00432	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methazolamide—glaucoma	0.00129	0.0043	CcSEcCtD
Rilpivirine—Fatigue—Methazolamide—glaucoma	0.00129	0.00429	CcSEcCtD
Rilpivirine—Urethral disorder—Brinzolamide—glaucoma	0.00128	0.00428	CcSEcCtD
Rilpivirine—Asthenia—Metipranolol—glaucoma	0.00128	0.00426	CcSEcCtD
Rilpivirine—Immune system disorder—Brimonidine—glaucoma	0.00126	0.0042	CcSEcCtD
Rilpivirine—Abdominal pain—Carbachol—glaucoma	0.00125	0.00417	CcSEcCtD
Rilpivirine—Mental disorder—Brimonidine—glaucoma	0.00122	0.00408	CcSEcCtD
Rilpivirine—Immune system disorder—Travoprost—glaucoma	0.0012	0.004	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.0012	0.00399	CcSEcCtD
Rilpivirine—Immune system disorder—Brinzolamide—glaucoma	0.00118	0.00395	CcSEcCtD
Rilpivirine—Asthenia—Carteolol—glaucoma	0.00118	0.00394	CcSEcCtD
Rilpivirine—Dry mouth—Apraclonidine—glaucoma	0.00118	0.00393	CcSEcCtD
Rilpivirine—Dizziness—Metipranolol—glaucoma	0.00118	0.00392	CcSEcCtD
Rilpivirine—Anxiety—Bimatoprost—glaucoma	0.00116	0.00388	CcSEcCtD
Rilpivirine—Asthenia—Diclofenamide—glaucoma	0.00116	0.00388	CcSEcCtD
Rilpivirine—Mental disorder—Travoprost—glaucoma	0.00116	0.00388	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00116	0.00387	CcSEcCtD
Rilpivirine—Mental disorder—Brinzolamide—glaucoma	0.00115	0.00383	CcSEcCtD
Rilpivirine—Infection—Apraclonidine—glaucoma	0.00115	0.00383	CcSEcCtD
Rilpivirine—Dry mouth—Bimatoprost—glaucoma	0.00114	0.00381	CcSEcCtD
Rilpivirine—Malnutrition—Brinzolamide—glaucoma	0.00114	0.0038	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00114	0.0038	CcSEcCtD
Rilpivirine—Nervous system disorder—Apraclonidine—glaucoma	0.00113	0.00378	CcSEcCtD
Rilpivirine—Rash—Metipranolol—glaucoma	0.00112	0.00374	CcSEcCtD
Rilpivirine—Skin disorder—Apraclonidine—glaucoma	0.00112	0.00374	CcSEcCtD
Rilpivirine—Dermatitis—Metipranolol—glaucoma	0.00112	0.00374	CcSEcCtD
Rilpivirine—Asthenia—Levobunolol—glaucoma	0.00112	0.00373	CcSEcCtD
Rilpivirine—Depression—Clonidine—glaucoma	0.00112	0.00373	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00112	0.00372	CcSEcCtD
Rilpivirine—Headache—Metipranolol—glaucoma	0.00111	0.00372	CcSEcCtD
Rilpivirine—Infection—Bimatoprost—glaucoma	0.00111	0.00371	CcSEcCtD
Rilpivirine—Nervous system disorder—Bimatoprost—glaucoma	0.0011	0.00366	CcSEcCtD
Rilpivirine—Dizziness—Carteolol—glaucoma	0.00109	0.00364	CcSEcCtD
Rilpivirine—Skin disorder—Bimatoprost—glaucoma	0.00109	0.00363	CcSEcCtD
Rilpivirine—Diarrhoea—Carbachol—glaucoma	0.00108	0.00361	CcSEcCtD
Rilpivirine—Dizziness—Diclofenamide—glaucoma	0.00107	0.00357	CcSEcCtD
Rilpivirine—Asthenia—Methazolamide—glaucoma	0.00107	0.00357	CcSEcCtD
Rilpivirine—Diarrhoea—Levobunolol—glaucoma	0.00107	0.00355	CcSEcCtD
Rilpivirine—Nausea—Metipranolol—glaucoma	0.00106	0.00353	CcSEcCtD
Rilpivirine—Dizziness—Carbachol—glaucoma	0.00105	0.00349	CcSEcCtD
Rilpivirine—Insomnia—Apraclonidine—glaucoma	0.00104	0.00348	CcSEcCtD
Rilpivirine—Headache—Carteolol—glaucoma	0.00103	0.00344	CcSEcCtD
Rilpivirine—Anxiety—Brimonidine—glaucoma	0.00103	0.00344	CcSEcCtD
Rilpivirine—Vomiting—Diclofenamide—glaucoma	0.00103	0.00344	CcSEcCtD
Rilpivirine—Dizziness—Levobunolol—glaucoma	0.00103	0.00344	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00103	0.00343	CcSEcCtD
Rilpivirine—Somnolence—Apraclonidine—glaucoma	0.00103	0.00342	CcSEcCtD
Rilpivirine—Rash—Diclofenamide—glaucoma	0.00102	0.00341	CcSEcCtD
Rilpivirine—Diarrhoea—Methazolamide—glaucoma	0.00102	0.00341	CcSEcCtD
Rilpivirine—Headache—Diclofenamide—glaucoma	0.00102	0.00339	CcSEcCtD
Rilpivirine—Insomnia—Bimatoprost—glaucoma	0.00101	0.00338	CcSEcCtD
Rilpivirine—Dry mouth—Brimonidine—glaucoma	0.00101	0.00337	CcSEcCtD
Rilpivirine—Vomiting—Carbachol—glaucoma	0.00101	0.00335	CcSEcCtD
Rilpivirine—Rash—Carbachol—glaucoma	0.000998	0.00333	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000997	0.00333	CcSEcCtD
Rilpivirine—Dermatitis—Carbachol—glaucoma	0.000997	0.00332	CcSEcCtD
Rilpivirine—Fatigue—Apraclonidine—glaucoma	0.000996	0.00332	CcSEcCtD
Rilpivirine—Somnolence—Bimatoprost—glaucoma	0.000996	0.00332	CcSEcCtD
Rilpivirine—Headache—Carbachol—glaucoma	0.000991	0.00331	CcSEcCtD
Rilpivirine—Infection—Brimonidine—glaucoma	0.000985	0.00328	CcSEcCtD
Rilpivirine—Anxiety—Dorzolamide—glaucoma	0.000984	0.00328	CcSEcCtD
Rilpivirine—Anxiety—Travoprost—glaucoma	0.00098	0.00327	CcSEcCtD
Rilpivirine—Nausea—Carteolol—glaucoma	0.000979	0.00327	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000977	0.00326	CcSEcCtD
Rilpivirine—Headache—Levobunolol—glaucoma	0.000976	0.00325	CcSEcCtD
Rilpivirine—Depression—Betaxolol—glaucoma	0.000973	0.00324	CcSEcCtD
Rilpivirine—Nervous system disorder—Brimonidine—glaucoma	0.000972	0.00324	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000967	0.00322	CcSEcCtD
Rilpivirine—Dry mouth—Dorzolamide—glaucoma	0.000966	0.00322	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000964	0.00322	CcSEcCtD
Rilpivirine—Skin disorder—Brimonidine—glaucoma	0.000963	0.00321	CcSEcCtD
Rilpivirine—Nausea—Diclofenamide—glaucoma	0.000963	0.00321	CcSEcCtD
Rilpivirine—Dry mouth—Travoprost—glaucoma	0.000962	0.00321	CcSEcCtD
Rilpivirine—Dizziness—Latanoprost—glaucoma	0.000955	0.00319	CcSEcCtD
Rilpivirine—Dry mouth—Brinzolamide—glaucoma	0.00095	0.00317	CcSEcCtD
Rilpivirine—Vomiting—Methazolamide—glaucoma	0.000949	0.00316	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000944	0.00315	CcSEcCtD
Rilpivirine—Rash—Methazolamide—glaucoma	0.000941	0.00314	CcSEcCtD
Rilpivirine—Dermatitis—Methazolamide—glaucoma	0.00094	0.00314	CcSEcCtD
Rilpivirine—Nausea—Carbachol—glaucoma	0.00094	0.00313	CcSEcCtD
Rilpivirine—Infection—Travoprost—glaucoma	0.000937	0.00312	CcSEcCtD
Rilpivirine—Headache—Methazolamide—glaucoma	0.000935	0.00312	CcSEcCtD
Rilpivirine—Anxiety—Pilocarpine—glaucoma	0.00093	0.0031	CcSEcCtD
Rilpivirine—Nausea—Levobunolol—glaucoma	0.000925	0.00309	CcSEcCtD
Rilpivirine—Infection—Brinzolamide—glaucoma	0.000925	0.00308	CcSEcCtD
Rilpivirine—Nervous system disorder—Travoprost—glaucoma	0.000925	0.00308	CcSEcCtD
Rilpivirine—Somnolence—Acetazolamide—glaucoma	0.000918	0.00306	CcSEcCtD
Rilpivirine—Skin disorder—Travoprost—glaucoma	0.000916	0.00305	CcSEcCtD
Rilpivirine—Abdominal pain—Apraclonidine—glaucoma	0.000913	0.00304	CcSEcCtD
Rilpivirine—Nervous system disorder—Brinzolamide—glaucoma	0.000913	0.00304	CcSEcCtD
Rilpivirine—Rash—Latanoprost—glaucoma	0.000911	0.00304	CcSEcCtD
Rilpivirine—Dermatitis—Latanoprost—glaucoma	0.00091	0.00303	CcSEcCtD
Rilpivirine—Headache—Latanoprost—glaucoma	0.000905	0.00302	CcSEcCtD
Rilpivirine—Skin disorder—Brinzolamide—glaucoma	0.000904	0.00302	CcSEcCtD
Rilpivirine—Decreased appetite—Acetazolamide—glaucoma	0.000898	0.00299	CcSEcCtD
Rilpivirine—Insomnia—Brimonidine—glaucoma	0.000897	0.00299	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000892	0.00297	CcSEcCtD
Rilpivirine—Fatigue—Acetazolamide—glaucoma	0.000891	0.00297	CcSEcCtD
Rilpivirine—Infection—Pilocarpine—glaucoma	0.000889	0.00296	CcSEcCtD
Rilpivirine—Nausea—Methazolamide—glaucoma	0.000887	0.00296	CcSEcCtD
Rilpivirine—Somnolence—Brimonidine—glaucoma	0.000882	0.00294	CcSEcCtD
Rilpivirine—Mental disorder—Clonidine—glaucoma	0.000881	0.00294	CcSEcCtD
Rilpivirine—Insomnia—Dorzolamide—glaucoma	0.000857	0.00286	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000856	0.00285	CcSEcCtD
Rilpivirine—Fatigue—Brimonidine—glaucoma	0.000855	0.00285	CcSEcCtD
Rilpivirine—Insomnia—Brinzolamide—glaucoma	0.000842	0.00281	CcSEcCtD
Rilpivirine—Somnolence—Dorzolamide—glaucoma	0.000842	0.00281	CcSEcCtD
Rilpivirine—Asthenia—Apraclonidine—glaucoma	0.000829	0.00276	CcSEcCtD
Rilpivirine—Somnolence—Brinzolamide—glaucoma	0.000828	0.00276	CcSEcCtD
Rilpivirine—Decreased appetite—Dorzolamide—glaucoma	0.000823	0.00275	CcSEcCtD
Rilpivirine—Fatigue—Dorzolamide—glaucoma	0.000816	0.00272	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Travoprost—glaucoma	0.000814	0.00271	CcSEcCtD
Rilpivirine—Fatigue—Travoprost—glaucoma	0.000813	0.00271	CcSEcCtD
Rilpivirine—Insomnia—Pilocarpine—glaucoma	0.000809	0.0027	CcSEcCtD
Rilpivirine—Decreased appetite—Brinzolamide—glaucoma	0.000809	0.0027	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000804	0.00268	CcSEcCtD
Rilpivirine—Asthenia—Bimatoprost—glaucoma	0.000803	0.00268	CcSEcCtD
Rilpivirine—Fatigue—Brinzolamide—glaucoma	0.000803	0.00268	CcSEcCtD
Rilpivirine—Somnolence—Pilocarpine—glaucoma	0.000796	0.00265	CcSEcCtD
Rilpivirine—Depression—Timolol—glaucoma	0.000795	0.00265	CcSEcCtD
Rilpivirine—Immune system disorder—Betaxolol—glaucoma	0.000791	0.00264	CcSEcCtD
Rilpivirine—Diarrhoea—Apraclonidine—glaucoma	0.00079	0.00264	CcSEcCtD
Rilpivirine—Decreased appetite—Pilocarpine—glaucoma	0.000778	0.00259	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000774	0.00258	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000773	0.00258	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Travoprost—glaucoma	0.000771	0.00257	CcSEcCtD
Rilpivirine—Mental disorder—Betaxolol—glaucoma	0.000767	0.00256	CcSEcCtD
Rilpivirine—Dizziness—Apraclonidine—glaucoma	0.000764	0.00255	CcSEcCtD
Rilpivirine—Malnutrition—Betaxolol—glaucoma	0.000762	0.00254	CcSEcCtD
Rilpivirine—Abdominal pain—Dorzolamide—glaucoma	0.000749	0.0025	CcSEcCtD
Rilpivirine—Abdominal pain—Travoprost—glaucoma	0.000745	0.00249	CcSEcCtD
Rilpivirine—Anxiety—Clonidine—glaucoma	0.000743	0.00248	CcSEcCtD
Rilpivirine—Asthenia—Acetazolamide—glaucoma	0.000741	0.00247	CcSEcCtD
Rilpivirine—Dizziness—Bimatoprost—glaucoma	0.000741	0.00247	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00074	0.00247	CcSEcCtD
Rilpivirine—Vomiting—Apraclonidine—glaucoma	0.000734	0.00245	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000732	0.00244	CcSEcCtD
Rilpivirine—Dry mouth—Clonidine—glaucoma	0.000729	0.00243	CcSEcCtD
Rilpivirine—Dermatitis—Apraclonidine—glaucoma	0.000728	0.00243	CcSEcCtD
Rilpivirine—Headache—Apraclonidine—glaucoma	0.000724	0.00241	CcSEcCtD
Rilpivirine—Asthenia—Brimonidine—glaucoma	0.000711	0.00237	CcSEcCtD
Rilpivirine—Infection—Clonidine—glaucoma	0.00071	0.00237	CcSEcCtD
Rilpivirine—Abdominal pain—Pilocarpine—glaucoma	0.000707	0.00236	CcSEcCtD
Rilpivirine—Diarrhoea—Acetazolamide—glaucoma	0.000707	0.00236	CcSEcCtD
Rilpivirine—Rash—Bimatoprost—glaucoma	0.000706	0.00235	CcSEcCtD
Rilpivirine—Dermatitis—Bimatoprost—glaucoma	0.000705	0.00235	CcSEcCtD
Rilpivirine—Headache—Bimatoprost—glaucoma	0.000702	0.00234	CcSEcCtD
Rilpivirine—Nervous system disorder—Clonidine—glaucoma	0.000701	0.00234	CcSEcCtD
Rilpivirine—Skin disorder—Clonidine—glaucoma	0.000694	0.00231	CcSEcCtD
Rilpivirine—Nausea—Apraclonidine—glaucoma	0.000686	0.00229	CcSEcCtD
Rilpivirine—Dizziness—Acetazolamide—glaucoma	0.000683	0.00228	CcSEcCtD
Rilpivirine—Asthenia—Dorzolamide—glaucoma	0.000679	0.00227	CcSEcCtD
Rilpivirine—Asthenia—Travoprost—glaucoma	0.000677	0.00226	CcSEcCtD
Rilpivirine—Asthenia—Brinzolamide—glaucoma	0.000668	0.00223	CcSEcCtD
Rilpivirine—Nausea—Bimatoprost—glaucoma	0.000665	0.00222	CcSEcCtD
Rilpivirine—Vomiting—Acetazolamide—glaucoma	0.000657	0.00219	CcSEcCtD
Rilpivirine—Dizziness—Brimonidine—glaucoma	0.000656	0.00219	CcSEcCtD
Rilpivirine—Diarrhoea—Dorzolamide—glaucoma	0.000648	0.00216	CcSEcCtD
Rilpivirine—Headache—Acetazolamide—glaucoma	0.000647	0.00216	CcSEcCtD
Rilpivirine—Anxiety—Betaxolol—glaucoma	0.000647	0.00216	CcSEcCtD
Rilpivirine—Insomnia—Clonidine—glaucoma	0.000646	0.00216	CcSEcCtD
Rilpivirine—Immune system disorder—Timolol—glaucoma	0.000646	0.00215	CcSEcCtD
Rilpivirine—Diarrhoea—Travoprost—glaucoma	0.000645	0.00215	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000645	0.00215	CcSEcCtD
Rilpivirine—Asthenia—Pilocarpine—glaucoma	0.000642	0.00214	CcSEcCtD
Rilpivirine—Diarrhoea—Brinzolamide—glaucoma	0.000637	0.00212	CcSEcCtD
Rilpivirine—Somnolence—Clonidine—glaucoma	0.000635	0.00212	CcSEcCtD
Rilpivirine—Dry mouth—Betaxolol—glaucoma	0.000635	0.00212	CcSEcCtD
Rilpivirine—Mental disorder—Timolol—glaucoma	0.000627	0.00209	CcSEcCtD
Rilpivirine—Dizziness—Dorzolamide—glaucoma	0.000626	0.00209	CcSEcCtD
Rilpivirine—Rash—Brimonidine—glaucoma	0.000625	0.00208	CcSEcCtD
Rilpivirine—Dermatitis—Brimonidine—glaucoma	0.000625	0.00208	CcSEcCtD
Rilpivirine—Dizziness—Travoprost—glaucoma	0.000624	0.00208	CcSEcCtD
Rilpivirine—Malnutrition—Timolol—glaucoma	0.000623	0.00208	CcSEcCtD
Rilpivirine—Headache—Brimonidine—glaucoma	0.000621	0.00207	CcSEcCtD
Rilpivirine—Decreased appetite—Clonidine—glaucoma	0.000621	0.00207	CcSEcCtD
Rilpivirine—Infection—Betaxolol—glaucoma	0.000618	0.00206	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Clonidine—glaucoma	0.000617	0.00206	CcSEcCtD
Rilpivirine—Fatigue—Clonidine—glaucoma	0.000616	0.00205	CcSEcCtD
Rilpivirine—Dizziness—Brinzolamide—glaucoma	0.000616	0.00205	CcSEcCtD
Rilpivirine—Nausea—Acetazolamide—glaucoma	0.000614	0.00205	CcSEcCtD
Rilpivirine—Diarrhoea—Pilocarpine—glaucoma	0.000612	0.00204	CcSEcCtD
Rilpivirine—Nervous system disorder—Betaxolol—glaucoma	0.00061	0.00203	CcSEcCtD
Rilpivirine—Skin disorder—Betaxolol—glaucoma	0.000604	0.00202	CcSEcCtD
Rilpivirine—Vomiting—Dorzolamide—glaucoma	0.000602	0.00201	CcSEcCtD
Rilpivirine—Rash—Dorzolamide—glaucoma	0.000597	0.00199	CcSEcCtD
Rilpivirine—Dermatitis—Dorzolamide—glaucoma	0.000597	0.00199	CcSEcCtD
Rilpivirine—Rash—Travoprost—glaucoma	0.000595	0.00198	CcSEcCtD
Rilpivirine—Dermatitis—Travoprost—glaucoma	0.000594	0.00198	CcSEcCtD
Rilpivirine—Headache—Dorzolamide—glaucoma	0.000593	0.00198	CcSEcCtD
Rilpivirine—Vomiting—Brinzolamide—glaucoma	0.000592	0.00197	CcSEcCtD
Rilpivirine—Dizziness—Pilocarpine—glaucoma	0.000592	0.00197	CcSEcCtD
Rilpivirine—Headache—Travoprost—glaucoma	0.000591	0.00197	CcSEcCtD
Rilpivirine—Nausea—Brimonidine—glaucoma	0.000589	0.00196	CcSEcCtD
Rilpivirine—Rash—Brinzolamide—glaucoma	0.000587	0.00196	CcSEcCtD
Rilpivirine—Dermatitis—Brinzolamide—glaucoma	0.000586	0.00196	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Clonidine—glaucoma	0.000584	0.00195	CcSEcCtD
Rilpivirine—Headache—Brinzolamide—glaucoma	0.000583	0.00194	CcSEcCtD
Rilpivirine—Vomiting—Pilocarpine—glaucoma	0.000569	0.0019	CcSEcCtD
Rilpivirine—Abdominal pain—Clonidine—glaucoma	0.000565	0.00188	CcSEcCtD
Rilpivirine—Rash—Pilocarpine—glaucoma	0.000564	0.00188	CcSEcCtD
Rilpivirine—Dermatitis—Pilocarpine—glaucoma	0.000564	0.00188	CcSEcCtD
Rilpivirine—Insomnia—Betaxolol—glaucoma	0.000563	0.00188	CcSEcCtD
Rilpivirine—Nausea—Dorzolamide—glaucoma	0.000563	0.00188	CcSEcCtD
Rilpivirine—Headache—Pilocarpine—glaucoma	0.000561	0.00187	CcSEcCtD
Rilpivirine—Nausea—Travoprost—glaucoma	0.00056	0.00187	CcSEcCtD
Rilpivirine—Nausea—Brinzolamide—glaucoma	0.000553	0.00184	CcSEcCtD
Rilpivirine—Decreased appetite—Betaxolol—glaucoma	0.000541	0.0018	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000537	0.00179	CcSEcCtD
Rilpivirine—Fatigue—Betaxolol—glaucoma	0.000536	0.00179	CcSEcCtD
Rilpivirine—Nausea—Pilocarpine—glaucoma	0.000532	0.00177	CcSEcCtD
Rilpivirine—Anxiety—Timolol—glaucoma	0.000528	0.00176	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000527	0.00176	CcSEcCtD
Rilpivirine—Dry mouth—Timolol—glaucoma	0.000519	0.00173	CcSEcCtD
Rilpivirine—Asthenia—Clonidine—glaucoma	0.000513	0.00171	CcSEcCtD
Rilpivirine—Infection—Timolol—glaucoma	0.000505	0.00168	CcSEcCtD
Rilpivirine—Nervous system disorder—Timolol—glaucoma	0.000498	0.00166	CcSEcCtD
Rilpivirine—Skin disorder—Timolol—glaucoma	0.000494	0.00165	CcSEcCtD
Rilpivirine—Diarrhoea—Clonidine—glaucoma	0.000489	0.00163	CcSEcCtD
Rilpivirine—Dizziness—Clonidine—glaucoma	0.000473	0.00158	CcSEcCtD
Rilpivirine—Insomnia—Timolol—glaucoma	0.00046	0.00153	CcSEcCtD
Rilpivirine—Vomiting—Clonidine—glaucoma	0.000454	0.00152	CcSEcCtD
Rilpivirine—Somnolence—Timolol—glaucoma	0.000452	0.00151	CcSEcCtD
Rilpivirine—Rash—Clonidine—glaucoma	0.000451	0.0015	CcSEcCtD
Rilpivirine—Dermatitis—Clonidine—glaucoma	0.00045	0.0015	CcSEcCtD
Rilpivirine—Headache—Clonidine—glaucoma	0.000448	0.00149	CcSEcCtD
Rilpivirine—Asthenia—Betaxolol—glaucoma	0.000446	0.00149	CcSEcCtD
Rilpivirine—Decreased appetite—Timolol—glaucoma	0.000442	0.00147	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Timolol—glaucoma	0.000439	0.00146	CcSEcCtD
Rilpivirine—Fatigue—Timolol—glaucoma	0.000438	0.00146	CcSEcCtD
Rilpivirine—Diarrhoea—Betaxolol—glaucoma	0.000426	0.00142	CcSEcCtD
Rilpivirine—Nausea—Clonidine—glaucoma	0.000424	0.00142	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Timolol—glaucoma	0.000416	0.00139	CcSEcCtD
Rilpivirine—Dizziness—Betaxolol—glaucoma	0.000411	0.00137	CcSEcCtD
Rilpivirine—Abdominal pain—Timolol—glaucoma	0.000402	0.00134	CcSEcCtD
Rilpivirine—Vomiting—Betaxolol—glaucoma	0.000396	0.00132	CcSEcCtD
Rilpivirine—Rash—Betaxolol—glaucoma	0.000392	0.00131	CcSEcCtD
Rilpivirine—Dermatitis—Betaxolol—glaucoma	0.000392	0.00131	CcSEcCtD
Rilpivirine—Headache—Betaxolol—glaucoma	0.00039	0.0013	CcSEcCtD
Rilpivirine—Nausea—Betaxolol—glaucoma	0.00037	0.00123	CcSEcCtD
Rilpivirine—Asthenia—Timolol—glaucoma	0.000365	0.00122	CcSEcCtD
Rilpivirine—Diarrhoea—Timolol—glaucoma	0.000348	0.00116	CcSEcCtD
Rilpivirine—Dizziness—Timolol—glaucoma	0.000336	0.00112	CcSEcCtD
Rilpivirine—Vomiting—Timolol—glaucoma	0.000323	0.00108	CcSEcCtD
Rilpivirine—Rash—Timolol—glaucoma	0.00032	0.00107	CcSEcCtD
Rilpivirine—Dermatitis—Timolol—glaucoma	0.00032	0.00107	CcSEcCtD
Rilpivirine—Headache—Timolol—glaucoma	0.000318	0.00106	CcSEcCtD
Rilpivirine—Nausea—Timolol—glaucoma	0.000302	0.00101	CcSEcCtD
Rilpivirine—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	9.32e-05	0.00902	CbGpPWpGaD
Rilpivirine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	9e-05	0.00871	CbGpPWpGaD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.78e-05	0.0085	CbGpPWpGaD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	8.26e-05	0.008	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	7.96e-05	0.00771	CbGpPWpGaD
Rilpivirine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	7.96e-05	0.0077	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—EDN1—glaucoma	7.73e-05	0.00748	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.7e-05	0.00745	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—PEX19—glaucoma	7.66e-05	0.00741	CbGpPWpGaD
Rilpivirine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	7.56e-05	0.00732	CbGpPWpGaD
Rilpivirine—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	7.46e-05	0.00722	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—glaucoma	7.4e-05	0.00716	CbGpPWpGaD
Rilpivirine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	7.19e-05	0.00696	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—PEX19—glaucoma	7.09e-05	0.00686	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	7.01e-05	0.00679	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	6.79e-05	0.00657	CbGpPWpGaD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	6.72e-05	0.00651	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.67e-05	0.00645	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	6.61e-05	0.0064	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	6.44e-05	0.00623	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NARFL—glaucoma	6.28e-05	0.00608	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CA5A—glaucoma	6.28e-05	0.00608	CbGpPWpGaD
Rilpivirine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.13e-05	0.00593	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—glaucoma	5.77e-05	0.00558	CbGpPWpGaD
Rilpivirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.71e-05	0.00553	CbGpPWpGaD
Rilpivirine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.64e-05	0.00546	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	5.51e-05	0.00533	CbGpPWpGaD
Rilpivirine—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	5.51e-05	0.00533	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	5.51e-05	0.00533	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	5.41e-05	0.00524	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	5.24e-05	0.00507	CbGpPWpGaD
Rilpivirine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.18e-05	0.00501	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.17e-05	0.00501	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	5.15e-05	0.00498	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.14e-05	0.00497	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	4.97e-05	0.00481	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—CDKN2B—glaucoma	4.92e-05	0.00477	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.79e-05	0.00464	CbGpPWpGaD
Rilpivirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.63e-05	0.00448	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.48e-05	0.00434	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—glaucoma	4.46e-05	0.00432	CbGpPWpGaD
Rilpivirine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	4.45e-05	0.00431	CbGpPWpGaD
Rilpivirine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	4.39e-05	0.00425	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—NR3C1—glaucoma	4.32e-05	0.00418	CbGpPWpGaD
Rilpivirine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	4.25e-05	0.00411	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NARFL—glaucoma	4.22e-05	0.00408	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CA5A—glaucoma	4.22e-05	0.00408	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	4.18e-05	0.00404	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GSTT1—glaucoma	4.11e-05	0.00398	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTT1—glaucoma	4.09e-05	0.00395	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NARFL—glaucoma	3.91e-05	0.00378	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CA5A—glaucoma	3.91e-05	0.00378	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	3.83e-05	0.00371	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.76e-05	0.00364	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.61e-05	0.00349	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—IL1A—glaucoma	3.6e-05	0.00348	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.45e-05	0.00334	CbGpPWpGaD
Rilpivirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.44e-05	0.00333	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.39e-05	0.00328	CbGpPWpGaD
Rilpivirine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.39e-05	0.00328	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—CYP1B1—glaucoma	3.26e-05	0.00315	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	3.21e-05	0.00311	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—FAS—glaucoma	3.21e-05	0.0031	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.2e-05	0.00309	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—C3—glaucoma	3.16e-05	0.00306	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTT1—glaucoma	3.09e-05	0.00299	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CA1—glaucoma	3.07e-05	0.00297	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	2.98e-05	0.00288	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CTSA—glaucoma	2.97e-05	0.00287	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CA5A—glaucoma	2.86e-05	0.00277	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NARFL—glaucoma	2.86e-05	0.00277	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CA2—glaucoma	2.8e-05	0.00271	CbGpPWpGaD
Rilpivirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	2.8e-05	0.00271	CbGpPWpGaD
Rilpivirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.78e-05	0.0027	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.74e-05	0.00265	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.74e-05	0.00265	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	2.71e-05	0.00262	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GSTM1—glaucoma	2.62e-05	0.00254	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTM1—glaucoma	2.6e-05	0.00252	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.59e-05	0.00251	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	2.57e-05	0.00248	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.53e-05	0.00245	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	2.48e-05	0.0024	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	2.46e-05	0.00238	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	2.43e-05	0.00235	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTT1—glaucoma	2.41e-05	0.00233	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—CDKN2B—glaucoma	2.37e-05	0.00229	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	2.35e-05	0.00227	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	2.35e-05	0.00227	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.34e-05	0.00226	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	2.32e-05	0.00225	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.3e-05	0.00222	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA5A—glaucoma	2.16e-05	0.00209	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NARFL—glaucoma	2.16e-05	0.00209	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NARFL—glaucoma	2.11e-05	0.00204	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA5A—glaucoma	2.11e-05	0.00204	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—NR3C1—glaucoma	2.08e-05	0.00201	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CA1—glaucoma	2.06e-05	0.00199	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.02e-05	0.00195	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CTSA—glaucoma	2e-05	0.00193	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TXN—glaucoma	1.98e-05	0.00191	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTM1—glaucoma	1.97e-05	0.0019	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	1.95e-05	0.00189	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	1.94e-05	0.00188	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	1.92e-05	0.00186	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CA1—glaucoma	1.91e-05	0.00185	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	1.89e-05	0.00183	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CA2—glaucoma	1.88e-05	0.00182	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.86e-05	0.0018	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.86e-05	0.0018	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.85e-05	0.00179	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CTSA—glaucoma	1.85e-05	0.00179	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.84e-05	0.00178	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.84e-05	0.00178	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.83e-05	0.00178	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.8e-05	0.00175	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.79e-05	0.00173	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.79e-05	0.00173	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CA2—glaucoma	1.74e-05	0.00169	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.73e-05	0.00167	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NARFL—glaucoma	1.69e-05	0.00163	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA5A—glaucoma	1.69e-05	0.00163	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.67e-05	0.00162	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.67e-05	0.00162	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.59e-05	0.00154	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.58e-05	0.00153	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTM1—glaucoma	1.53e-05	0.00148	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTT1—glaucoma	1.53e-05	0.00148	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	1.51e-05	0.00146	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	1.48e-05	0.00143	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	1.46e-05	0.00141	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CA1—glaucoma	1.4e-05	0.00135	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—TNF—glaucoma	1.36e-05	0.00132	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CTSA—glaucoma	1.35e-05	0.00131	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.35e-05	0.00131	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TXN—glaucoma	1.33e-05	0.00129	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NARFL—glaucoma	1.3e-05	0.00126	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA5A—glaucoma	1.3e-05	0.00126	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CA2—glaucoma	1.28e-05	0.00124	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.26e-05	0.00122	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.24e-05	0.0012	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TXN—glaucoma	1.23e-05	0.00119	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CYP1B1—glaucoma	1.22e-05	0.00118	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—ABCA1—glaucoma	1.22e-05	0.00118	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.21e-05	0.00117	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.2e-05	0.00116	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.18e-05	0.00114	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.17e-05	0.00113	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA1—glaucoma	1.06e-05	0.00102	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA1—glaucoma	1.03e-05	0.000998	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTT1—glaucoma	1.03e-05	0.000996	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CTSA—glaucoma	1.02e-05	0.000991	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CTSA—glaucoma	9.99e-06	0.000967	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	9.95e-06	0.000963	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTM1—glaucoma	9.76e-06	0.000945	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CA2—glaucoma	9.66e-06	0.000935	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTT1—glaucoma	9.53e-06	0.000923	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	9.45e-06	0.000914	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	9.45e-06	0.000914	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CA2—glaucoma	9.43e-06	0.000913	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	9.42e-06	0.000912	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TXN—glaucoma	9.01e-06	0.000872	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—MTHFR—glaucoma	8.62e-06	0.000835	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.3e-06	0.000803	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA1—glaucoma	8.23e-06	0.000797	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—ABCA1—glaucoma	8.2e-06	0.000794	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CYP1B1—glaucoma	8.2e-06	0.000794	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—APOE—glaucoma	8.03e-06	0.000777	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CTSA—glaucoma	7.97e-06	0.000772	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CAV1—glaucoma	7.96e-06	0.00077	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.84e-06	0.000759	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—ABCA1—glaucoma	7.59e-06	0.000735	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CYP1B1—glaucoma	7.59e-06	0.000735	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CA2—glaucoma	7.53e-06	0.000729	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.36e-06	0.000712	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.36e-06	0.000712	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTT1—glaucoma	6.99e-06	0.000676	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TXN—glaucoma	6.81e-06	0.000659	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.72e-06	0.00065	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TXN—glaucoma	6.65e-06	0.000643	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTM1—glaucoma	6.56e-06	0.000635	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA1—glaucoma	6.35e-06	0.000615	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	6.21e-06	0.000601	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	6.16e-06	0.000596	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CTSA—glaucoma	6.15e-06	0.000596	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTM1—glaucoma	6.07e-06	0.000588	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—NOS3—glaucoma	6.02e-06	0.000582	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.92e-06	0.000573	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CA2—glaucoma	5.81e-06	0.000563	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—MTHFR—glaucoma	5.79e-06	0.000561	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CYP1B1—glaucoma	5.57e-06	0.000539	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—ABCA1—glaucoma	5.57e-06	0.000539	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—glaucoma	5.5e-06	0.000533	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOE—glaucoma	5.39e-06	0.000522	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—MTHFR—glaucoma	5.37e-06	0.000519	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CAV1—glaucoma	5.35e-06	0.000517	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TXN—glaucoma	5.31e-06	0.000514	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTT1—glaucoma	5.28e-06	0.000511	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTT1—glaucoma	5.15e-06	0.000499	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—glaucoma	5e-06	0.000484	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CAV1—glaucoma	4.95e-06	0.000479	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.84e-06	0.000469	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.8e-06	0.000464	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTM1—glaucoma	4.45e-06	0.000431	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.26e-06	0.000412	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—ABCA1—glaucoma	4.21e-06	0.000407	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CYP1B1—glaucoma	4.21e-06	0.000407	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTT1—glaucoma	4.11e-06	0.000398	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CYP1B1—glaucoma	4.11e-06	0.000397	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—ABCA1—glaucoma	4.11e-06	0.000397	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TXN—glaucoma	4.09e-06	0.000396	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—NOS3—glaucoma	4.04e-06	0.000391	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—MTHFR—glaucoma	3.93e-06	0.000381	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—NOS3—glaucoma	3.74e-06	0.000362	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—glaucoma	3.7e-06	0.000358	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—glaucoma	3.66e-06	0.000354	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CAV1—glaucoma	3.63e-06	0.000351	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—glaucoma	3.42e-06	0.000331	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTM1—glaucoma	3.36e-06	0.000326	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.32e-06	0.000321	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTM1—glaucoma	3.28e-06	0.000318	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—ABCA1—glaucoma	3.28e-06	0.000317	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CYP1B1—glaucoma	3.28e-06	0.000317	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTT1—glaucoma	3.17e-06	0.000307	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—MTHFR—glaucoma	2.97e-06	0.000288	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—MTHFR—glaucoma	2.9e-06	0.000281	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—glaucoma	2.77e-06	0.000268	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—NOS3—glaucoma	2.74e-06	0.000266	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CAV1—glaucoma	2.74e-06	0.000265	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—glaucoma	2.7e-06	0.000261	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CAV1—glaucoma	2.68e-06	0.000259	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTM1—glaucoma	2.62e-06	0.000254	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—ABCA1—glaucoma	2.53e-06	0.000245	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CYP1B1—glaucoma	2.53e-06	0.000245	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—glaucoma	2.51e-06	0.000243	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—MTHFR—glaucoma	2.32e-06	0.000224	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—glaucoma	2.16e-06	0.000209	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CAV1—glaucoma	2.14e-06	0.000207	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—NOS3—glaucoma	2.07e-06	0.000201	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—NOS3—glaucoma	2.02e-06	0.000196	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTM1—glaucoma	2.02e-06	0.000196	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—glaucoma	1.9e-06	0.000184	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—glaucoma	1.85e-06	0.000179	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—MTHFR—glaucoma	1.79e-06	0.000173	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—glaucoma	1.66e-06	0.000161	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CAV1—glaucoma	1.65e-06	0.00016	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—NOS3—glaucoma	1.62e-06	0.000156	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—glaucoma	1.48e-06	0.000143	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—NOS3—glaucoma	1.25e-06	0.000121	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—glaucoma	1.14e-06	0.00011	CbGpPWpGaD
